Drug
EMB-01
EMB-01 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Other(3)
Detailed Status
unknown3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
recruiting125%
unknown375%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NCT05176665
unknownphase_1
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
NCT05498389
unknownphase_1
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
NCT03797391
unknownphase_2
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
NCT04868253
Clinical Trials (4)
Showing 4 of 4 trials
NCT05176665Phase 1
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
NCT05498389Phase 1
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
NCT03797391Phase 1
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
NCT04868253Phase 2
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4